BioCopy
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hochbergerstrasse 60f, Basel, Basel-City...Phone Number
+49 76419377870Website
www.biocopy.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About BioCopy
BioCopy is a pioneering company focused on developing next-generation cancer therapeutics through an AI-driven platform. They specialize in drug discovery and antibody engineering, offering precision screening and an automated lab that significantly enhances the speed of biotherapeutic development. Their unique end-to-end automated system leverages extensive proprietary data to optimize the drug discovery process. BioCopy aims to revolutionize how cancer is treated by delivering safe, effective, and targeted treatments.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioCopy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BioCopy has new funding data
Earning: See what the market has to say on BioCopy recently announced quarterly report
Check if BioCopy has recently received funding, and reach out quickly before it becomes old news!
BioCopy, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if BioCopy is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BioCopy
Click to see if BioCopy had a recent Job posting/layoffs
Product Launch: Get notified when BioCopy launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined BioCopy as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
BioCopy is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioCopy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioCopy.
BioCopy Tech Stack
A closer look at the technologies used by BioCopy
BioCopy News & Media
BioCopy Chooses Genedata for AI-Powered Multispecific Antibody Discovery
Cutting-edge biotech builds on best-in-class software to automate R&D workflows for designing novel drug candidates using machine learning approaches BASEL, Switzerland, July 17, 2024 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for...Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies
BEIJING--(BUSINESS WIRE)-- #Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG (“BioCopy”), a research-based biotechnology company headquartered in Basel, Switzerland. The agreement grants BioCopy access to fully human TCR-mimic antibodies targeting an intracellular antige
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding BioCopy
Sign Up For FreeTo access detailed company insights
BioCopy is a pioneering company focused on developing next-generation cancer therapeutics through an AI-driven platform. They specialize in drug discovery and antibody engineering, offering precision screening and an automated lab that significantly enhances the speed of biotherapeutic development. Their unique end-to-end automated system leverages... Read More
